AdaptHealth Q3 net income $22.9M, revenue $805.9M; raises free cash flow guidance

AdaptHealth Corp.

2024-Q3 EPS reported $0.27 revenue$2,404,330,000

Net income attributable to AdaptHealth of $22.9M vs net loss of $454.1M in Q3 2023.
Revenue $805.9M, up 0.2% YoY; Adjusted EBITDA $164.3M, up 1.9%.
FY 2024 guidance updated: revenue $3.22-3.26B (down), adjusted EBITDA $655-675M (narrowed), free cash flow $175-195M (up from $160-180M).
Year-to-date free cash flow $162.7M, more than double prior year's $76.6M.
Completed sale of certain custom rehab assets during the quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.